Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Is Pursuing Its Own Pharma Fraud Investigations; DoJ Nets $2.5 Bil. In FY 2010

Executive Summary

One sign that the government is zealously going after the pharmaceutical industry for health care fraud is the line up of criminal investigations FDA has initiated.
Advertisement

Related Content

FDA Opened 16 Health Care Fraud Investigations In FY 2011; DoJ Net Tops $4 Billion
Off-Label Prosecution May Be Where FDA "Parks" Aggressive Enforcement Tools First
Off-Label Prosecution May Be Where FDA "Parks" Aggressive Enforcement Tools First
Novartis Settlement Encompasses Whistleblower Claims Of Kickbacks For Diovan Prescribing
Botox Reimbursement Training Is Driving Factor In Allergan Settlement With DOJ
AstraZeneca's Seroquel Settlement With DoJ Is Fourth Targeting Antipsychotic Off-Label Promotion; Firm Avoids Criminal Charges

Topics

Advertisement
UsernamePublicRestriction

Register

PS053076

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel